BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

977 related articles for article (PubMed ID: 26026972)

  • 21. Prevalence of important pathogens and the antimicrobial activity of parenteral drugs at numerous medical centers in the United States. II. Study of the intra- and interlaboratory dissemination of extended-spectrum beta-lactamase-producing Enterobacteriaceae.
    Sader HS; Pfaller MA; Jones RN
    Diagn Microbiol Infect Dis; 1994 Dec; 20(4):203-8. PubMed ID: 7705033
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surveillance and Resistance of Community-Onset Extended-Spectrum β-Lactamase-Producing
    He C; Wu S; Wang X; Li L; Yan Z
    Surg Infect (Larchmt); 2024 Apr; 25(3):247-252. PubMed ID: 38588519
    [No Abstract]   [Full Text] [Related]  

  • 23. Wastewater from healthcare centers in Burkina Faso is a source of ESBL, AmpC-β-lactamase and carbapenemase-producing Escherichia coli and Klebsiella pneumoniae.
    Garba Z; Bonkoungou IOJ; Millogo NO; Natama HM; Vokouma PAP; Bonko MDA; Karama I; Tiendrebeogo LAW; Haukka K; Tinto H; Sangaré L; Barro N
    BMC Microbiol; 2023 Nov; 23(1):351. PubMed ID: 37978428
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rapid detection of fosfomycin resistance in Escherichia coli and Klebsiella spp. strains isolated from urinary tract infections.
    Kansak N; Arıcı N; Adaleti R; Nakipoglu Y; Aksaray S
    J Microbiol Methods; 2021 Sep; 188():106296. PubMed ID: 34333048
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antimicrobial resistance and AmpC production in ESBL-producing Klebsiella pneumoniae and Klebsiella quasipneumoniae: A retrospective study in Japanese clinical isolates.
    Watanabe N; Watari T; Otsuka Y; Ito M; Yamagata K; Fujioka M
    PLoS One; 2024; 19(5):e0303353. PubMed ID: 38743684
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inactivation of
    Hirakawa H; Takita A; Sato Y; Hiramoto S; Hashimoto Y; Ohshima N; Minamishima YA; Murakami M; Tomita H
    Microbiol Spectr; 2023 Jun; 11(3):e0506922. PubMed ID: 37199605
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antimicrobial resistance in uropathogens and appropriateness of empirical treatment: a population-based surveillance study in Indonesia.
    Sugianli AK; Ginting F; Kusumawati RL; Pranggono EH; Pasaribu AP; Gronthoud F; Geerlings S; Parwati I; De Jong MD; Van Leth F; Schultsz C
    J Antimicrob Chemother; 2017 May; 72(5):1469-1477. PubMed ID: 28137940
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical and microbiological characteristics of nosocomial, healthcare-associated, and community-acquired Klebsiella pneumoniae infections in Guangzhou, China.
    Le T; Wang L; Zeng C; Fu L; Liu Z; Hu J
    Antimicrob Resist Infect Control; 2021 Feb; 10(1):41. PubMed ID: 33632338
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Investigation of Fosfomycin Susceptibility in Extended Spectrum Beta-Lactamase Producing Enteric Bacteria by Disk Diffusion, Automated System and Agar Dilütion Kit].
    Soydan G; Görgülü Y; Öztürk C
    Mikrobiyol Bul; 2021 Oct; 55(4):617-625. PubMed ID: 34666660
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coexistence Of Blaoxa-48, Blavim, And Blashv Genes In Klebsiella Pneumoniae And Escherichia Coli Isolated From Urinary Tract Infections: Microbiological And Epidemiological Analysis.
    Abdallah M; Haroun S; Tahoun A; Hegazy YM; Eldomany R
    J Pak Med Assoc; 2023 Apr; 73(Suppl 4)(4):S294-S304. PubMed ID: 37482876
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antimicrobial Activity of Gepotidacin Tested against Escherichia coli and Staphylococcus saprophyticus Isolates Causing Urinary Tract Infections in Medical Centers Worldwide (2019 to 2020).
    Arends SJR; Butler D; Scangarella-Oman N; Castanheira M; Mendes RE
    Antimicrob Agents Chemother; 2023 Apr; 67(4):e0152522. PubMed ID: 36877017
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spectrum and antibiotic resistance in community- and hospital-acquired urinary tract infections among adults: Experience from a large tertiary care center in a developing country.
    Herbawi A; Abu Taha A; Aiesh BM; Sabateen A; Zyoud SH
    Urologia; 2024 May; 91(2):394-402. PubMed ID: 38488375
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Community carriage of ESBL-producing
    Raffelsberger N; Buczek DJ; Svendsen K; Småbrekke L; Pöntinen AK; Löhr IH; Andreassen LLE; Simonsen GS; ; Sundsfjord A; Gravningen K; Samuelsen Ø
    mSphere; 2023 Aug; 8(4):e0002523. PubMed ID: 37306968
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fecal carriage of extended spectrum β-lactamase producing Escherichia coli and Klebsiella pneumoniae after urinary tract infection - A three year prospective cohort study.
    Jørgensen SB; Søraas A; Sundsfjord A; Liestøl K; Leegaard TM; Jenum PA
    PLoS One; 2017; 12(3):e0173510. PubMed ID: 28267783
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacodynamics of Finafloxacin, Ciprofloxacin, and Levofloxacin in Serum and Urine against TEM- and SHV-Type Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae Isolates from Patients with Urinary Tract Infections.
    Dalhoff A; Schubert S; Vente A
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28193648
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High clonal diversity of ESBL-producing
    Xercavins M; Jiménez E; Padilla E; Riera M; Freixas N; Boix-Palop L; Pérez J; Calbo E
    Antimicrob Resist Infect Control; 2020; 9(1):5. PubMed ID: 31911833
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibiotic Resistance Pattern of Extended Spectrum Beta Lactamase Producing
    Kettani Halabi M; Lahlou FA; Diawara I; El Adouzi Y; Marnaoui R; Benmessaoud R; Smyej I
    Front Cell Infect Microbiol; 2021; 11():720701. PubMed ID: 34490146
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Virulent-MDR-ESBL E. coli and Klebsiella pneumoniae report from North Sinai calves diarrhea and in vitro antimicrobial by Moringa oleifera.
    Allam SA; Elnomrosy SM; Mohamed SM
    BMC Vet Res; 2024 Jun; 20(1):259. PubMed ID: 38877453
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diversity of Carbapenemase-Producing Escherichia coli Isolates in France in 2012-2013.
    Gauthier L; Dortet L; Cotellon G; Creton E; Cuzon G; Ponties V; Bonnin RA; Naas T
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29866863
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The susceptibility of multidrug resistant and biofilm forming
    Damiano P; Salema EJ; Silago V
    Malawi Med J; 2021 Mar; 33(1):59-64. PubMed ID: 34422235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 49.